XPH News and Press, SPDR S&P Pharmaceuticals From 05/29/23

2023-05-29 09:00:00 ET Summary PFE's historical stock performance remains mediocre compared to its pharmaceutical peers, even after adjusting for dividends. Combined with its decelerating COVID-19 portfolio and $22B worth of annualized patent cliff from 2025 onwards, we are not su...

2023-05-17 00:15:00 ET Summary One of the most promising applications of AI in drug discovery is in the identification of new drug targets (AI can be used to discover new drugs). The ability to analyze large amounts of molecular and genomic data quickly and efficiently is somethin...

2023-05-17 00:00:00 ET Summary Markets are being shaped by disparate trends from falling energy prices to rising interest rates. During first-quarter earnings season, company reports indicated that these crosscurrents are intensifying business challenges—and making it harde...

2023-05-16 14:35:00 ET Summary Both the Consumer Price Index and Producer Price Index data for April confirmed that the strong but lumpy disinflationary trend continues. The US is now at a point where the Fed funds rate exceeds inflation. Historically that has signaled the end of ...

2023-05-10 06:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Amphenol Corporation (NYSE: APH) announced today that its Board of Directors approved the second quarter 2023 dividend on its Common Stock in the amount of $0.21 per share at its meeting held on May 4, 2023. The Company will pay this second quarter 2023 dividend on July 12, 2023 to shareholders o...

2023-05-02 01:25:00 ET Summary Interest rates continue to drive markets, with central banks walking a fine line between taming inflation and avoiding recession. The Fed isn’t quite finished with the tightening cycle yet, even as the market remains optimistic that rates will...

2023-04-30 14:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

First Quarter 2023 Highlights: Sales of $2.974 billion, up 1% in U.S. dollars and organically compared to the first quarter of 2022 GAAP Diluted EPS of $0.71, up 4% compared to prior year Adjusted Diluted EPS of $0.69, up 3% compared to prior year GAAP and Adjusted Ope...

2023-04-20 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...